Susquehanna Portfolio Strategies, LLC

Position in CRSP — CRISPR Therapeutics AG

CIK 1996449 Bala Cynwyd, PA

Position in CRSP

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$8,945,978

+$3,933,385 QoQ

Shares Held

164,026

+55.7% QoQ

Ownership

0.170%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

#46

of 521 holders

Holding Since

Dec 2023

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Susquehanna Portfolio Strategies, LLC holds $399,265,861 across 121 Biotechnology names. CRSP ranks #10 (2.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	90,928	$45,166,665
2	MRNA	Moderna, Inc.	471,043	$32,987,141
3	CORT	Corcept Therapeutics Inc	211,017	$18,347,928
4	BBIO	BridgeBio Pharma, Inc.	226,869	$16,897,203
5	BMRN	Biomarin Pharmaceutical Inc	273,562	$15,653,217
6	HALO	Halozyme Therapeutics, Inc.	166,503	$13,032,189
7	EXEL	Exelixis, Inc.	229,749	$12,500,643
8	MDGL	Madrigal Pharmaceuticals, Inc.	22,003	$11,814,510

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,945,978	164,026	+55.7%	Shares	Sole	2026-08-14
2026-03-31	$5,012,593	105,373	+239.7%	Shares	Sole	2026-05-15
2025-12-31	$1,626,426	31,015	-17.3%	Shares	Sole	2026-02-17
2025-09-30	$2,429,986	37,494	+20.9%	Shares	Sole	2025-11-14
2025-06-30	$1,508,569	31,015	+62.8%	Shares	Sole	2025-08-14
2025-03-31	$648,271	19,050	+225.9%	Shares	Sole	2025-05-14
2024-06-30	$315,688	5,845	-84.3%	Shares	Defined	2024-08-15
2024-03-31	$2,540,868	37,278	-48.4%	Shares	Defined	2024-05-07
2023-12-31	$4,525,792	72,297	—	Shares	Defined	2024-02-14
No filing history on record for this holder in this stock.